Treatment of refractory delayed onset heparin‐induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)

ESSENTIALS: Delayed‐onset heparin‐induced thrombocytopenia can lead to severe thrombocytopenia in the setting of recent major vascular surgery. Intravenous immunoglobulin (IVIG) can be used as a supplementary treatment when platelet count fails to improve with conventional treatment. When platelet c...

Descripción completa

Detalles Bibliográficos
Autores principales: Doucette, Kimberley, DeStefano, Christin B., Jain, Natasha A., Cruz, Allan L., Malkovska, Vera, Fitzpatrick, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Online‐only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058197/
https://www.ncbi.nlm.nih.gov/pubmed/30046682
http://dx.doi.org/10.1002/rth2.12009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058197/
https://www.ncbi.nlm.nih.gov/pubmed/30046682
http://dx.doi.org/10.1002/rth2.12009

Ejemplares similares